业绩超预期却未上调展望直觉外科股价重挫逾11%

环球市场播报07-17

手术机器人公司直觉外科周四盘后公布第二季度财报，营收和利润均超出市场预期，但公司维持全年手术量增长展望不变，令期待上调指引的投资者失望，股价盘后重挫逾11%。　　财报显示，第二季度营收同比增长19%至28.9亿美元，高于市场预期的28.2亿美元；调整后每股收益2.80美元，远超预期的2.50美元，较去年同期的2.19美元增长28%。全球达芬奇及Ion平台手术量合计增长16%，其中达芬奇手术量增长...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohunote.com/m/news/2652838912?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-07-17 20:24","share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","id":"2652838912","market":"sh","top_or_hot":-1,"title":"业绩超预期却未上调展望 直觉外科股价重挫逾11%","media":"环球市场播报","content":"<div>\n<p>手术机器人公司直觉外科周四盘后公布第二季度财报，营收和利润均超出市场预期，但公司维持全年手术量增长展望不变，令期待上调指引的投资者失望，股价盘后重挫逾11%。\n　　财报显示，第二季度营收同比增长19%至28.9亿美元，高于市场预期的28.2亿美元；调整后每股收益2.80美元，远超预期的2.50美元，较去年同期的2.19美元增长28%。全球达芬奇及Ion平台手术量合计增长16%，其中达芬奇手术量增长...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/usstock/c/2026-07-17/doc-iniickaw4209197.shtml\">网页链接</a>\n\n</div>\n","source":"sina","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>业绩超预期却未上调展望 直觉外科股价重挫逾11%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n业绩超预期却未上调展望 直觉外科股价重挫逾11%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-07-17 20:24 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/stock/usstock/c/2026-07-17/doc-iniickaw4209197.shtml><strong>环球市场播报</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>手术机器人公司直觉外科周四盘后公布第二季度财报，营收和利润均超出市场预期，但公司维持全年手术量增长展望不变，令期待上调指引的投资者失望，股价盘后重挫逾11%。\n　　财报显示，第二季度营收同比增长19%至28.9亿美元，高于市场预期的28.2亿美元；调整后每股收益2.80美元，远超预期的2.50美元，较去年同期的2.19美元增长28%。全球达芬奇及Ion平台手术量合计增长16%，其中达芬奇手术量增长...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/usstock/c/2026-07-17/doc-iniickaw4209197.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IHI","symbol_name":"iShares Dow Jones U.S. Medical D","start_time":0,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-07-17/doc-iniickaw4209197.shtml","article_id":"2652838912","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2652838912","pubTimestamp":1784291040,"columns":[],"sourceInfo":{"source_id":"sina","name":"sina"},"weMediaInfo":null,"summary":"手术机器人公司直觉外科周四盘后公布第二季度财报，营收和利润均超出市场预期，但公司维持全年手术量增长展望不变，令期待上调指引的投资者失望，股价盘后重挫逾11%。全球达芬奇及Ion平台手术量合计增长16%，其中达芬奇手术量增长15%，Ion手术量增长36%。截至季末，全球达芬奇系统装机量达11，710台，同比增长12%。受此影响，直觉外科股价今年已累计下跌约30%，估值持续收缩。","collect":0,"end_time":0,"defaultTopTitle":"sina.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"IHI":"iShares Dow Jones U.S. Medical D","LU0097036916.USD":"贝莱德美国增长A2 USD","LU2265009873.SGD":"Eastspring Investments - Global Growth Equity AS SGD-H","IE00B19Z8X17.USD":"FTGF CLEARBRIDGE US LARGE CAP GROWTH  \"AG\" (USD) ACC","LU0882574055.USD":"富达全球健康医疗A ACC","IE00B5TLWC47.USD":"BNY MELLON LONG-TERM GLOBAL EQUITY \"B\" (USD) ACC","LU0079474960.USD":"联博美国增长基金A","EKG":"First Trust Nasdaq Lux Digital Health Solutions ETF","LU0096364046.USD":"CT (LUX) I AMERICAN \"DU\" (USD) ACC","LU1974910355.USD":"Allianz Thematica Cl AMg DIS USD","LU0823416689.USD":"BNP PARIBAS HEALTH CARE INNOVATORS \"C\" (USD) ACC","LU0122379950.USD":"贝莱德世界健康科学A2","BK4585":"ETF&股票定投概念","LU2433249047.HKD":"THEMATICS META \"R/A\" (HKD) ACC","IE00BYQQ9H92.USD":"BNY MELLON GLOBAL LEADERS \"A\" (USD) ACC","BK4534":"瑞士信贷持仓","LU0823434583.USD":"BNP PARIBAS US GROWTH \"C\" (USD) ACC","LU1951198990.SGD":"Natixis Thematics AI & Robotics Fund H-R/A SGD-H","LU2063271972.USD":"富兰克林创新领域基金","BK4548":"巴美列捷福持仓","LU0354030511.USD":"ALLSPRING  U.S. LARGE CAP GROWTH \"I\" (USD) ACC","LU0823434740.USD":"BNP PARIBAS US GROWTH \"C\" (USD) INC","LU1951200564.SGD":"Natixis Thematics AI & Robotics Fund R/A SGD","LU1989764748.USD":"东方汇理环球颠覆性机遇A2 Acc","LU0390134368.USD":"FRANKLIN GLOBAL GROWTH \"A\" (USD) ACC","LU0354030438.USD":"富国美国大盘成长基金Cl A Acc","LU1868837300.USD":"CT (LUX) I AMERICAN FUND \"9\" (USD) ACC","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","BK4504":"桥水持仓","LU2023250504.SGD":"Allianz Thematica Cl AMg DIS H2-SGD","LGHT":"LANGAR GLOBAL HEALTHTECH ETF","LU2023250843.SGD":"Allianz Thematica Cl AT Acc H2-SGD","LU2125909247.SGD":"Natixis Thematics Meta H-R/A SGD","LU1917777945.USD":"安联专题基金Cl AT Acc","BK4588":"碎股","LU0432979614.USD":"JPM GLOBAL HEALTHCARE \"A\" ACC","IE00B19Z9505.USD":"美盛-美国大盘成长股A Acc","LU1868837136.USD":"CT (LUX) I AMERICAN \"8\" (USD) ACC","LU1804176565.USD":"EASTSPRING INV GLOBAL GROWTH EQUITY \"A\" (USD) ACC","IE00BFXG0V08.USD":"BNY MELLON GLOBAL LEADERS \"B\" (USD) ACC","LU0238689110.USD":"贝莱德环球动力股票基金","LU2112291526.USD":"BGF WORLD HEALTHSCIENCE \"A4\" (USD) INC","LU1868836591.USD":"CT (LUX) I AMERICAN \"1U\"(USD) ACC","ISRG":"直觉外科公司","LU2125909593.SGD":"Natixis Thematics Meta R/A SGD","IE00B19Z8W00.USD":"FTGF CLEARBRIDGE US LARGE CAP GROWTH \"A\" INC","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","LU2106854487.HKD":"ALLIANZ THEMATICA \"AMG\" (HKD) INC","LU1868836757.USD":"CT (LUX) I AMERICAN FUND \"2\" (USD) ACC","ISUL":"2倍做多ISRG ETF-GraniteShares"},"translate_title":"Performance exceeds expectations without raising outlook Intuitive Surgical shares plunge more than 11%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IHI":0.6,"ISUL":0.6,"ISRG":1.5,"EKG":0.6,"LGHT":0.6},"content_text":"手术机器人公司直觉外科周四盘后公布第二季度财报，营收和利润均超出市场预期，但公司维持全年手术量增长展望不变，令期待上调指引的投资者失望，股价盘后重挫逾11%。\n　　财报显示，第二季度营收同比增长19%至28.9亿美元，高于市场预期的28.2亿美元；调整后每股收益2.80美元，远超预期的2.50美元，较去年同期的2.19美元增长28%。全球达芬奇及Ion平台手术量合计增长16%，其中达芬奇手术量增长15%，Ion手术量增长36%。\n　　公司当季共安装468台达芬奇手术系统，高于去年同期的395台，其中246台为新一代达芬奇5系统。截至季末，全球达芬奇系统装机量达11，710台，同比增长12%。\n　　尽管业绩亮眼，但公司维持2026年全年达芬奇手术量增长13.5%至15.5%的展望不变，预计全年增速接近该区间中点。这一指引意味着全年增速将较2025年的17.7%明显放缓，创下2020年以来最慢增速。花旗分析师指出，投资者已将预期提高，公司未上调展望令市场失望。\n　　美国市场增速放缓引发担忧。第二季度美国达芬奇手术量增长12%，低于公司年初预期，主要是可延期手术受到影响。公司表示，部分患者因医保覆盖和保费变化而推迟就医。Evercore ISI分析师指出，美国手术量增速为三年来最低，重新引发市场对医保政策影响的讨论。\n　　竞争加剧也是投资者担忧因素之一。美敦力正寻求扩大其Hugo手术系统在美国的适应症范围，强生等对手也在布局。受此影响，直觉外科股价今年已累计下跌约30%，估值持续收缩。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张俊 SF065","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2652838912","isCrawlerRequest":true}

业绩超预期却未上调展望 直觉外科股价重挫逾11%

精彩评论

业绩超预期却未上调展望直觉外科股价重挫逾11%